Shugaban kamfanin Merck a Faransa ya amsa kiran cibiyar kiwon lafiya
Wani reshen Faransa na kamfanin harhada magunguna na kasar Jamus Merck ya sanar a yau Laraba ya amsa kira daga masu bincike dangane da tuhume-tuhumen da ake yi masa na yaudara tare da sauya tsarin maganin Levothyrox.
Wallafawa ranar:
A jiya talata an saurari shugaban kamfanin Merck a Faransa a cibiyar kiwon lafiya ta kotun Marseilles, kamar dai yadda kungiyar ta fitar a cikin wata sanarwa , inda daga karshe alkalin kotun ya yanke shawarar maka kamfanin Merck a gaban shari'a kan zamba.
Laifin yana da alaƙa da hanyoyin bayanan da aka sanya a lokacin sauye-sauye daga tsohuwar zuwa sabuwar dabara a cikin 2017, an tsara magani a kan hypothyroidism.
Sabon maganin da ke tattare da miyagun ƙwayoyi, yana canza wasu abubuwan.
An zargi kamfani, tsakanin Maris 2017 da Afrilu 2018,bayan da aka gano wasu marasa lafiya 31,000 da ke fama da ciwon kai, rashin barci.
An kaddamar da bincike na yaudara, kisan kai da rauni.
A bangaren farar hula, kotun daukaka kara ta yi watsi da karar da kungiyar ta shigar a watan maris, tare da neman biyan diyya.
LabaranSamun Labaran RFI, Hirarraki, Rubattattuun Labarai, Labarai game da wani, shirye-shirye.
Hulda da mu